Sort
48,018 grants matching “immunotherapy”
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$386,033Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2021 · NS
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$386,033Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2020 · NS
Epigenetic Regulation of Plasma Cells Differentiation
$386,019Jeremy M. Boss · Emory University · R01 · FY2019 · AI
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
$386,010Rebekah White · University Of California, San Diego · R01 · FY2022 · CA
Targeting the liver for immunotherapy in pancreatic cancer
$385,938Gregory L Beatty · University Of Pennsylvania · R01 · FY2025 · CA
Targeting the liver for immunotherapy in pancreatic cancer
$385,938Gregory L Beatty · University Of Pennsylvania · R01 · FY2022 · CA
Initiation of Immune Response in Chronic Leishmaniasis
$385,914Phillip A. Scott · University Of Pennsylvania · R01 · FY2011 · AI
Initiation of Immune Response in Chronic Leishmaniasis
$385,914Phillip A. Scott · University Of Pennsylvania · R01 · FY2012 · AI
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$385,902Minah Kim · Columbia University Health Sciences · R37 · FY2022 · CA
Applying deep learning to predict T cell receptor binding specificity of neoantigens and response to checkpoint inhibitors
$385,855Tao Wang · Ut Southwestern Medical Center · R01 · FY2024 · CA
DENDRITIC CELL THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA
$385,731Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · CA
Induction of Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplant
$385,724Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2009 · AI
Regulation of Macrophage- and Microglia-mediated STING Signaling in Glioblastoma
$385,723Rongze Olivia Lu · University Of California, San Francisco · R01 · FY2025 · NS
Genetic dissection of Id3-mediated pathways in gamma/delta lineage development
$385,710Yuan Zhuang · Research Inst Of Fox Chase Can Ctr · P01 · FY2018 · AI
Neural Stem Cell Carriers for Glioblastoma Immunotherapy
$385,694Irina V Balyasnikova · Northwestern University At Chicago · R21 · FY2018 · NS
CD8 T Cell Replicative Senescence &HIV Disease
$385,626University Of California Los Angeles · R01 · FY2005 · AI
Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies
$385,609Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Engineering of pan-neutralizing anti-HIV envelope antibodies
$385,595Mohammad Mohseni Sajadi · University Of Maryland Baltimore · R01 · FY2024 · AI
Functional reprogramming of tumor-MDSC through antibody-based therapies targeting Notch ligands
$385,581Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Regulation of dendritic cell function and tumor immunity by TIM-3
$385,581Brian Ruffell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation
$385,581Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Functional reprogramming of tumor-MDSC through antibody-based therapies targeting Notch ligands
$385,581Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation
$385,581Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
T. forsythia TLR2 ligands and surface glycans coordinate periodontal inflammation
$385,577Ashu Sharma · State University Of New York At Buffalo · R01 · FY2014 · DE
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM
$385,560Fox Chase Cancer Center · K12 · FY2001 · CA